Skip to main content
Erschienen in: Cellular Oncology 5/2016

15.06.2016 | Original Paper

MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression

verfasst von: Meixiang Xu, Courtney E. Cross, Jordan T. Speidel, Sherif Z. Abdel-Rahman

Erschienen in: Cellular Oncology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The O6-methylguanine-DNA methyltransferase (MGMT) protein removes O6-alkyl-guanine adducts from DNA. MGMT expression can thus alter the sensitivity of cells and tissues to environmental and chemotherapeutic alkylating agents. Previously, we defined the haplotype structure encompassing single nucleotide polymorphisms (SNPs) in the MGMT promoter/enhancer (P/E) region and found that haplotypes, rather than individual SNPs, alter MGMT promoter activity. The exact mechanism(s) by which these haplotypes exert their effect on MGMT promoter activity is currently unknown, but we noted that many of the SNPs comprising the MGMT P/E haplotypes are located within or in close proximity to putative transcription factor binding sites. Thus, these haplotypes could potentially affect transcription factor binding and, subsequently, alter MGMT promoter activity.

Methods

In this study, we test the hypothesis that MGMT P/E haplotypes affect MGMT promoter activity by altering transcription factor (TF) binding to the P/E region. We used a promoter binding TF profiling array and a reporter assay to evaluate the effect of different P/E haplotypes on TF binding and MGMT expression, respectively.

Results

Our data revealed a significant difference in TF binding profiles between the different haplotypes evaluated. We identified TFs that consistently showed significant haplotype-dependent binding alterations (p ≤ 0.01) and revealed their role in regulating MGMT expression using siRNAs and a dual-luciferase reporter assay system.

Conclusions

The data generated support our hypothesis that promoter haplotypes alter the binding of TFs to the MGMT P/E and, subsequently, affect their regulatory function on MGMT promoter activity and expression level.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat R. A. Becker, R. Montesano, Repair of O 4-methyldeoxythymidine residues in DNA by mammalian liver extracts. Carcinogenesis 6, 313–317 (1985)CrossRefPubMed R. A. Becker, R. Montesano, Repair of O 4-methyldeoxythymidine residues in DNA by mammalian liver extracts. Carcinogenesis 6, 313–317 (1985)CrossRefPubMed
2.
Zurück zum Zitat M. Christmann, B. Verbeek, W. P. Roos, B. Kaina, O(6)-methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. Biochim. Biophys. Acta 1816, 179–190 (2011) M. Christmann, B. Verbeek, W. P. Roos, B. Kaina, O(6)-methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. Biochim. Biophys. Acta 1816, 179–190 (2011)
3.
Zurück zum Zitat D. S. Daniels, T. T. Woo, K. X. Luu, D. M. Noll, N. D. Clarke, A. E. Pegg, J. A. Tainer, DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat. Struct. Mol. Biol. 11, 714–720 (2004) D. S. Daniels, T. T. Woo, K. X. Luu, D. M. Noll, N. D. Clarke, A. E. Pegg, J. A. Tainer, DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat. Struct. Mol. Biol. 11, 714–720 (2004)
4.
Zurück zum Zitat A. E. Pegg, Mammalian O 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50, 6119–6129 (1990) A. E. Pegg, Mammalian O 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50, 6119–6129 (1990)
5.
Zurück zum Zitat P. E. Jackson, C. N. Hall, A. F. Badawi, P. J. O’Connor, D. P. Cooper, A. C. Povey, Frequency of Ki-ras mutations and DNA alkylation in colourectal tissue from individuals living in Manchester. Mol. Carcinog. 16, 12–19 (1996) P. E. Jackson, C. N. Hall, A. F. Badawi, P. J. O’Connor, D. P. Cooper, A. C. Povey, Frequency of Ki-ras mutations and DNA alkylation in colourectal tissue from individuals living in Manchester. Mol. Carcinog. 16, 12–19 (1996)
6.
Zurück zum Zitat A. E. Pegg, Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res. 462, 83–100 (2000) A. E. Pegg, Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res. 462, 83–100 (2000)
7.
Zurück zum Zitat S. L. Gerson, Clinical relevance of MGMT in the treatment of cancer. J. Clin. Oncol. 20, 2388–2399 (2002)CrossRefPubMed S. L. Gerson, Clinical relevance of MGMT in the treatment of cancer. J. Clin. Oncol. 20, 2388–2399 (2002)CrossRefPubMed
8.
Zurück zum Zitat S. L. Gerson, MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer 4, 296–307 (2004)CrossRefPubMed S. L. Gerson, MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer 4, 296–307 (2004)CrossRefPubMed
9.
Zurück zum Zitat G. P. Margison, M. F. Santibáñez Koref, A. C. Povey, Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis 17, 483–487 (2002)CrossRefPubMed G. P. Margison, M. F. Santibáñez Koref, A. C. Povey, Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis 17, 483–487 (2002)CrossRefPubMed
10.
Zurück zum Zitat G. P. Margison, A. C. Povey, B. Kaina, M. F. Santibáñez Koref, Variability and regulation of O 6-alkylguanine-DNA alkyltransferase. Carcinogenesis 24, 625–635 (2003)CrossRefPubMed G. P. Margison, A. C. Povey, B. Kaina, M. F. Santibáñez Koref, Variability and regulation of O 6-alkylguanine-DNA alkyltransferase. Carcinogenesis 24, 625–635 (2003)CrossRefPubMed
11.
Zurück zum Zitat J. R. Silber, M. S. Bobola, A. Blank, M. C. Chamberlain, O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim. Biophys. Acta 1826, 71–82 (2012)PubMedPubMedCentral J. R. Silber, M. S. Bobola, A. Blank, M. C. Chamberlain, O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim. Biophys. Acta 1826, 71–82 (2012)PubMedPubMedCentral
12.
Zurück zum Zitat W. Wick, M. Weller, M. van den Bent, M. Sanson, M. Weiler, A. von Deimling, C. Plass, M. Hegi, M. Platten, G. Reifenberger, MGMT testing–the challenges for biomarker-based glioma treatment. Nat. Rev. Neurol. 10(7), 372–385 (2014)CrossRefPubMed W. Wick, M. Weller, M. van den Bent, M. Sanson, M. Weiler, A. von Deimling, C. Plass, M. Hegi, M. Platten, G. Reifenberger, MGMT testing–the challenges for biomarker-based glioma treatment. Nat. Rev. Neurol. 10(7), 372–385 (2014)CrossRefPubMed
13.
Zurück zum Zitat B. Kaina, M. Christmann, S. Naumann, W. P. Roos, MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 6, 1079–1099 (2007) B. Kaina, M. Christmann, S. Naumann, W. P. Roos, MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 6, 1079–1099 (2007)
14.
Zurück zum Zitat A. E. Pegg, Q. Fang, N. A. Loktionova, Human variants of O6-alkylguanine-DNA alkyltransferase. DNA Repair 6, 1071–1078 (2007) A. E. Pegg, Q. Fang, N. A. Loktionova, Human variants of O6-alkylguanine-DNA alkyltransferase. DNA Repair 6, 1071–1078 (2007)
15.
Zurück zum Zitat K. K. Bhakat, S. Mitra, CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Carcinogenesis 24, 1337–1345 (2003)CrossRefPubMed K. K. Bhakat, S. Mitra, CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Carcinogenesis 24, 1337–1345 (2003)CrossRefPubMed
16.
Zurück zum Zitat R. P. Danam, S. R. Howell, T. P. Brent, L. C. Harris, Epigenetic regulation of O 6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Mol. Cancer Ther. 4, 61–69 (2005)PubMed R. P. Danam, S. R. Howell, T. P. Brent, L. C. Harris, Epigenetic regulation of O 6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Mol. Cancer Ther. 4, 61–69 (2005)PubMed
17.
Zurück zum Zitat M. Krześniak, D. Butkiewicz, A. Samojedny, M. Chorazy, M. Rusin, Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet. 68, 300–312 (2004)CrossRefPubMed M. Krześniak, D. Butkiewicz, A. Samojedny, M. Chorazy, M. Rusin, Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet. 68, 300–312 (2004)CrossRefPubMed
18.
Zurück zum Zitat S. Ogino, A. Hazra, G. J. Tranah, G. J. Kirkner, T. Kawasaki, K. Nosho, M. Ohnishi, Y. Suemoto, J. A. Meyerhardt, D. J. Hunter, et al., MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colourectal cancer. Carcinogenesis 28, 1985–1990 (2007)CrossRefPubMed S. Ogino, A. Hazra, G. J. Tranah, G. J. Kirkner, T. Kawasaki, K. Nosho, M. Ohnishi, Y. Suemoto, J. A. Meyerhardt, D. J. Hunter, et al., MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colourectal cancer. Carcinogenesis 28, 1985–1990 (2007)CrossRefPubMed
19.
Zurück zum Zitat S. Leng, A. M. Bernauer, C. Hong, K. C. Do, C. M. Yingling, K. G. Flores, M. Tessema, C. S. Tellez, R. P. Willink, E. A. Burki, et al., The a/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin. Cancer Res. 17, 2014–2023 (2011)CrossRefPubMedPubMedCentral S. Leng, A. M. Bernauer, C. Hong, K. C. Do, C. M. Yingling, K. G. Flores, M. Tessema, C. S. Tellez, R. P. Willink, E. A. Burki, et al., The a/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin. Cancer Res. 17, 2014–2023 (2011)CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat K. L. McDonald, R. W. Rapkins, J. Olivier, L. Zhao, K. Nozue, D. Lu, S. Tiwari, J. Kuroiwa-Trzmielina, J. Brewer, H. R. Wheeler, et al., The T genotype of the MGMT C > T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients. Eur. J. Cancer 49, 360–368 (2013)CrossRefPubMed K. L. McDonald, R. W. Rapkins, J. Olivier, L. Zhao, K. Nozue, D. Lu, S. Tiwari, J. Kuroiwa-Trzmielina, J. Brewer, H. R. Wheeler, et al., The T genotype of the MGMT C > T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients. Eur. J. Cancer 49, 360–368 (2013)CrossRefPubMed
21.
Zurück zum Zitat M. Xu, I. Nekhayeva, C. E. Cross, C. M. Rondelli, J. K. Wickliffe, S. Z. Abdel-Rahman, Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents. Carcinogenesis 35(3), 564–571 (2014)CrossRefPubMed M. Xu, I. Nekhayeva, C. E. Cross, C. M. Rondelli, J. K. Wickliffe, S. Z. Abdel-Rahman, Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents. Carcinogenesis 35(3), 564–571 (2014)CrossRefPubMed
22.
Zurück zum Zitat S. E. Johnatty, M. Abdellatif, L. Shimmin, R. B. Clark, E. Boerwinkle, Beta 2 adrenergic receptor 5′ haplotypes influence promoter activity. Br. J. Pharmacol. 137, 1213–1216 (2002)CrossRefPubMedPubMedCentral S. E. Johnatty, M. Abdellatif, L. Shimmin, R. B. Clark, E. Boerwinkle, Beta 2 adrenergic receptor 5′ haplotypes influence promoter activity. Br. J. Pharmacol. 137, 1213–1216 (2002)CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat H. Takane, D. Kobayashi, T. Hirota, J. Kigawa, N. Terakawa, K. Otsubo, I. Ieiri, Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J. Pharmacol. Exp. Ther. 311, 1179–1187 (2004)CrossRefPubMed H. Takane, D. Kobayashi, T. Hirota, J. Kigawa, N. Terakawa, K. Otsubo, I. Ieiri, Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J. Pharmacol. Exp. Ther. 311, 1179–1187 (2004)CrossRefPubMed
24.
Zurück zum Zitat N. J. Hawkins, J. H. Lee, J. J. Wong, C. T. Kwok, R. L. Ward, M. P. Hitchins, MGMT methylation is associated primarily with the germline C > T SNP (rs16906252) in colourectal cancer and normal colonic mucosa. Mod. Pathol. 22, 1588–1599 (2009)CrossRefPubMed N. J. Hawkins, J. H. Lee, J. J. Wong, C. T. Kwok, R. L. Ward, M. P. Hitchins, MGMT methylation is associated primarily with the germline C > T SNP (rs16906252) in colourectal cancer and normal colonic mucosa. Mod. Pathol. 22, 1588–1599 (2009)CrossRefPubMed
25.
Zurück zum Zitat I. L. Candiloro, A. Dobrovic, Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev. Res. 2, 862–867 (2009)CrossRef I. L. Candiloro, A. Dobrovic, Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev. Res. 2, 862–867 (2009)CrossRef
26.
Zurück zum Zitat L. S. Kristensen, H. M. Nielsen, H. Hager, L. L. Hansen, Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. Lung Cancer 71, 130–136 (2011)CrossRefPubMed L. S. Kristensen, H. M. Nielsen, H. Hager, L. L. Hansen, Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. Lung Cancer 71, 130–136 (2011)CrossRefPubMed
27.
Zurück zum Zitat M. H. Chae, J. S. Jang, H. G. Kang, J. H. Park, J. M. Park, W. K. Lee, S. Kam, E. B. Lee, J. W. Son, J. Y. Park, O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol. Carcinog. 45, 239–249 (2006)CrossRefPubMed M. H. Chae, J. S. Jang, H. G. Kang, J. H. Park, J. M. Park, W. K. Lee, S. Kam, E. B. Lee, J. W. Son, J. Y. Park, O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol. Carcinog. 45, 239–249 (2006)CrossRefPubMed
28.
Zurück zum Zitat Z. Hu, H. Wang, M. Shao, G. Jin, W. Sun, Y. Wang, H. Liu, Y. Wang, H. Ma, J. Qian, et al., Genetic variants in MGMT and risk of lung cancer in southeastern Chinese: a haplotype-based analysis. Hum. Mutat. 28, 431–440 (2007)CrossRefPubMed Z. Hu, H. Wang, M. Shao, G. Jin, W. Sun, Y. Wang, H. Liu, Y. Wang, H. Ma, J. Qian, et al., Genetic variants in MGMT and risk of lung cancer in southeastern Chinese: a haplotype-based analysis. Hum. Mutat. 28, 431–440 (2007)CrossRefPubMed
29.
Zurück zum Zitat L. Wang, H. Liu, Z. Zhang, M. R. Spitz, Q. Wei, Association of genetic variants of O 6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic whites. Cancer Epidemiol. Biomark. Prev. 15, 2364–2369 (2006) L. Wang, H. Liu, Z. Zhang, M. R. Spitz, Q. Wei, Association of genetic variants of O 6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic whites. Cancer Epidemiol. Biomark. Prev. 15, 2364–2369 (2006)
30.
Zurück zum Zitat J. H. Park, N. S. Kim, J. Y. Park, Y. S. Chae, J. G. Kim, S. K. Sohn, J. H. Moon, B. W. Kang, H. M. Ryoo, S. H. Bae, et al., MGMT -535G > T polymorphism is associated with prognosis for patients with metastatic colourectal cancer treated with oxaliplatin-based chemotherapy. J. Cancer Res. Clin. Oncol. 136, 1135–1142 (2010) J. H. Park, N. S. Kim, J. Y. Park, Y. S. Chae, J. G. Kim, S. K. Sohn, J. H. Moon, B. W. Kang, H. M. Ryoo, S. H. Bae, et al., MGMT -535G > T polymorphism is associated with prognosis for patients with metastatic colourectal cancer treated with oxaliplatin-based chemotherapy. J. Cancer Res. Clin. Oncol. 136, 1135–1142 (2010)
31.
Zurück zum Zitat I. Zawlik, S. Vaccarella, D. Kita, M. Mittelbronn, S. Franceschi, H. Ohgaki, Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology 32, 21–29 (2009)CrossRefPubMed I. Zawlik, S. Vaccarella, D. Kita, M. Mittelbronn, S. Franceschi, H. Ohgaki, Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology 32, 21–29 (2009)CrossRefPubMed
32.
Zurück zum Zitat J. Felsberg, M. Rapp, S. Loeser, R. Fimmers, W. Stummer, M. Goeppert, H. J. Steiger, B. Friedensdorf, G. Reifenberger, M. C. Sabel, Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin. Cancer Res. 15, 6683–6693 (2009) J. Felsberg, M. Rapp, S. Loeser, R. Fimmers, W. Stummer, M. Goeppert, H. J. Steiger, B. Friedensdorf, G. Reifenberger, M. C. Sabel, Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin. Cancer Res. 15, 6683–6693 (2009)
33.
Zurück zum Zitat Z. Zhang, L. Wang, S. Wei, Z. Liu, L. E. Wang, E. M. Sturgis, Q. Wei, Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair 9, 558–566 (2010) Z. Zhang, L. Wang, S. Wei, Z. Liu, L. E. Wang, E. M. Sturgis, Q. Wei, Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair 9, 558–566 (2010)
34.
Zurück zum Zitat S. B. Gabriel, S. F. Schaffner, H. Nguyen, J. M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner, M. Faggart, et al., The structure of haplotype blocks in the human genome. Science 296, 2225–2229 (2002)CrossRefPubMed S. B. Gabriel, S. F. Schaffner, H. Nguyen, J. M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner, M. Faggart, et al., The structure of haplotype blocks in the human genome. Science 296, 2225–2229 (2002)CrossRefPubMed
35.
Zurück zum Zitat L. C. Harris, P. M. Potter, K. Tano, S. Shiota, S. Mitra, T. P. Brent, Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res. 19, 6163–6167 (1991) L. C. Harris, P. M. Potter, K. Tano, S. Shiota, S. Mitra, T. P. Brent, Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res. 19, 6163–6167 (1991)
36.
Zurück zum Zitat M. Christmann, B. Kaina, Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation. Nucleic Acids Res. 41, 8403–8420 (2013) M. Christmann, B. Kaina, Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation. Nucleic Acids Res. 41, 8403–8420 (2013)
37.
Zurück zum Zitat X. Messeguer, R. Escudero, D. Farré, O. Nuñez, J. Martínez, M. M. Albà, PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333–334 (2002) X. Messeguer, R. Escudero, D. Farré, O. Nuñez, J. Martínez, M. M. Albà, PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333–334 (2002)
38.
Zurück zum Zitat D. Farré, R. Roset, M. Huerta, J. E. Adsuara, L. Roselló, M. M. Albà, X. Messeguer, Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31, 3651–3653 (2003) D. Farré, R. Roset, M. Huerta, J. E. Adsuara, L. Roselló, M. M. Albà, X. Messeguer, Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31, 3651–3653 (2003)
39.
Zurück zum Zitat A. Yousuf, M. Y. Bhat Arshad, A. Pandith, D. Afroze, N. P. Khan, K. Alam, P. Shah, M. A. Shah, S. Mudassar, MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell. Oncol. 37, 245–252 (2014) A. Yousuf, M. Y. Bhat Arshad, A. Pandith, D. Afroze, N. P. Khan, K. Alam, P. Shah, M. A. Shah, S. Mudassar, MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell. Oncol. 37, 245–252 (2014)
40.
Zurück zum Zitat I. Boldogh, C. V. Ramana, Z. Chen, T. Biswas, T. K. Hazra, S. Grösch, T. Grombacher, S. Mitra, B. Kaina, Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. Cancer Res. 58, 3950–3956 (1998)PubMed I. Boldogh, C. V. Ramana, Z. Chen, T. Biswas, T. K. Hazra, S. Grösch, T. Grombacher, S. Mitra, B. Kaina, Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. Cancer Res. 58, 3950–3956 (1998)PubMed
41.
Zurück zum Zitat J. F. Costello, B. W. Futscher, R. A. Kroes, R. O. Pieper, Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol. Cell. Biol. 14, 6515–6521 (1994) J. F. Costello, B. W. Futscher, R. A. Kroes, R. O. Pieper, Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol. Cell. Biol. 14, 6515–6521 (1994)
42.
Zurück zum Zitat I. Lavon, D. Fuchs, D. Zrihan, G. Efroni, B. Zelikovitch, Y. Fellig, T. Siegal, Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase. Cancer Res. 67, 8952–8959 (2007)CrossRefPubMed I. Lavon, D. Fuchs, D. Zrihan, G. Efroni, B. Zelikovitch, Y. Fellig, T. Siegal, Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase. Cancer Res. 67, 8952–8959 (2007)CrossRefPubMed
43.
Zurück zum Zitat L. Persano, F. Pistollato, E. Rampazzo, A. Della Puppa, S. Abbadi, C. Frasson, F. Volpin, S. Indraccolo, R. Scienza, G. Basso, BMP2 sensitizes glioblastoma stem-like cells to temozolomide by affecting HIF-1α stability and MGMT expression. Cell Death Dis. 3, e412 (2012) L. Persano, F. Pistollato, E. Rampazzo, A. Della Puppa, S. Abbadi, C. Frasson, F. Volpin, S. Indraccolo, R. Scienza, G. Basso, BMP2 sensitizes glioblastoma stem-like cells to temozolomide by affecting HIF-1α stability and MGMT expression. Cell Death Dis. 3, e412 (2012)
44.
Zurück zum Zitat S. Ueda, T. Mineta, Y. Nakahara, H. Okamoto, T. Shiraishi, K. Tabuchi, Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J. Neurosurg. 101, 659–663 (2004)CrossRefPubMed S. Ueda, T. Mineta, Y. Nakahara, H. Okamoto, T. Shiraishi, K. Tabuchi, Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J. Neurosurg. 101, 659–663 (2004)CrossRefPubMed
45.
Zurück zum Zitat K. K. Bhakat, S. Mitra, Regulation of the human O6-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300. J. Biol. Chem. 275, 34197–34204 (2000) K. K. Bhakat, S. Mitra, Regulation of the human O6-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300. J. Biol. Chem. 275, 34197–34204 (2000)
46.
Zurück zum Zitat K. S. Srivenugopal, J. Shou, S. R. Mullapudi, F. F. Lang Jr., J. S. Rao, F. Ali-Osman, Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. Clin. Cancer Res. 7, 1398–1409 (2001) K. S. Srivenugopal, J. Shou, S. R. Mullapudi, F. F. Lang Jr., J. S. Rao, F. Ali-Osman, Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. Clin. Cancer Res. 7, 1398–1409 (2001)
47.
Zurück zum Zitat A. Natsume, D. Ishii, T. Wakabayashi, T. Tsuno, H. Hatano, M. Mizuno, J. Yoshida, IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res. 65, 7573–7579 (2005) A. Natsume, D. Ishii, T. Wakabayashi, T. Tsuno, H. Hatano, M. Mizuno, J. Yoshida, IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res. 65, 7573–7579 (2005)
48.
Zurück zum Zitat A. Reményi, H. R. Schöler, M. Wilmanns, Combinatorial control of gene expression. Nat. Struct. Mol. Biol. 11, 812–815 (2004) A. Reményi, H. R. Schöler, M. Wilmanns, Combinatorial control of gene expression. Nat. Struct. Mol. Biol. 11, 812–815 (2004)
49.
Zurück zum Zitat R. Pique-Regi, J. F. Degner, A. A. Pai, D. J. Gaffney, Y. Gila, J. K. Pritchard, Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res. 21(3), 447–455 (2011) R. Pique-Regi, J. F. Degner, A. A. Pai, D. J. Gaffney, Y. Gila, J. K. Pritchard, Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res. 21(3), 447–455 (2011)
50.
Zurück zum Zitat C. J. Fry, P. J. Farnham, Context-dependent transcriptional regulation. J. Biol. Chem. 274, 29583–29586 (1999) C. J. Fry, P. J. Farnham, Context-dependent transcriptional regulation. J. Biol. Chem. 274, 29583–29586 (1999)
51.
Zurück zum Zitat K. Vazquez-Santillan, J. Melendez-Zajgla, L. Jimenez-Hernandez, G. Martínez-Ruiz, V. Maldonado, NF-κB signaling in cancer stem cells: a promising therapeutic target? Cell. Oncol. 38, 327–339 (2015) K. Vazquez-Santillan, J. Melendez-Zajgla, L. Jimenez-Hernandez, G. Martínez-Ruiz, V. Maldonado, NF-κB signaling in cancer stem cells: a promising therapeutic target? Cell. Oncol. 38, 327–339 (2015)
Metadaten
Titel
MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression
verfasst von
Meixiang Xu
Courtney E. Cross
Jordan T. Speidel
Sherif Z. Abdel-Rahman
Publikationsdatum
15.06.2016
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 5/2016
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-016-0286-4

Weitere Artikel der Ausgabe 5/2016

Cellular Oncology 5/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie